183
Economical and stable even for 3 months at room temperature, ZyCoV-D will be the first DNA vaccine against Sars-CoV-2 to be administered on a large scale. In fact, in August, India approved it and plans to start distribution in the over-12 population very soon, probably as early as September. Despite its effectiveness is “only” of 66.6%
.